NU-DERM SYSTEM NORMAL-DRY SKIN TRANSFORMATION TRIAL is a Kit in the Human Prescription Drug category. It is labeled and distributed by Omp, Inc.. The primary component is .
Product ID | 62032-522_25fd5bb4-16d0-408c-b0dd-5e6981f225d7 |
NDC | 62032-522 |
Product Type | Human Prescription Drug |
Proprietary Name | NU-DERM SYSTEM NORMAL-DRY SKIN TRANSFORMATION TRIAL |
Generic Name | Hydroquinone, Octinoxate,and Zinc Oxide |
Dosage Form | Kit |
Marketing Start Date | 2013-04-15 |
Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
Labeler Name | OMP, INC. |
Active Ingredient Strength | 0 |
NDC Exclude Flag | E |
Listing Certified Through | 2018-12-31 |
Marketing Start Date | 2013-04-15 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | Unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2013-04-15 |
SPL SET ID: | b47c6867-ea72-443a-a6f1-6c122124f0fb |
Manufacturer | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
62032-516 | NU-DERM SYSTEM NORMAL-DRY SKIN TRANSFORMATION TRIAL | NU-DERM SYSTEM NORMAL-DRY SKIN TRANSFORMATION TRIAL |
62032-532 | NU-DERM system NORMAL-DRY SKIN TRANSFORMATION TRIAL | NU-DERM system NORMAL-DRY SKIN TRANSFORMATION TRIAL |
62032-514 | NU-DERM SYSTEM NORMAL-DRY | Hydroquinone, Octinoxate,and Zinc Oxide |
62032-522 | NU-DERM SYSTEM NORMAL-DRY | Hydroquinone, Octinoxate,and Zinc Oxide |